15 Biggest Mid-Day Losers For Tuesday

by Lisa Levin, Benzinga Editor
June 27, 2017 12:55 PM | 2 min read |
  • Ra Pharmaceuticals Inc RARX shares dipped 22 percent to $17.30 after the company issued updates on Phase 2 trial of RA101495.
  • Xenon Pharmaceuticals Inc XENE shares dropped 20.6 percent to $3.02 after the company reported results from Phase II study of TV-45070 in patients with PHN. The study did not meet primary and secondary endpoints.
  • Rewalk Robotics Ltd RWLK shares dropped 18.3 percent to $2.45 after surging 25.00 percent on Monday.
  • Alder Biopharmaceuticals Inc ALDR shares declined 17.7 percent to $15.40 despite PROMISE 1 Phase 3 trial which met primary and secondary endpoints. Several notable parts of data set were concerning, namely statistical significance for 100mg dose, and against placebo.
  • Camtek LTD. CAMT shares dipped 12.3 percent to $5.18 after rising 2.25 percent on Monday.
  • Finjan Holdings, Inc. FNJN dropped 12.2 percent to $3.18. Finjan priced 3.6 million shares at $3.15 per share.
  • Matinas BioPharma Holdings Inc MTNB shares declined 11 percent to $1.78.
  • Presbia PLC LENS shares fell 10.9 percent to $2.41.
  • Digiliti Money Group Inc DGLT shares declined 10.1 percent to $2.97.
  • Shiloh Industries, Inc. SHLO shares slipped 9.7 percent to $12.77.
  • IMPINJ Inc PI shares dropped 9.5 percent to $53.76. Pacific Crest downgraded Impinj from Overweight to Sector Weight.
  • Avis Budget Group Inc. CAR shares fell 8.2 percent to $25.39. Avis announced Monday it has formed a partnership with Alphabet Inc GOOGL’s autonomous car business, Waymo.
  • WhiteHorse Finance Inc WHF slipped 6.6 percent to $13.43. WhiteHorse Finance reported an offering of 2.5 million shares of common stock.
  • ARMOUR Residential REIT, Inc. ARR shares declined 5 percent to $26.11. ARMOUR Residential REIT reported a 4.5 million share common stock offering.
  • Neos Therapeutics Inc NEOS shares declined 4.8 percent to $7.00. Neos Therapeutics reported a $30 million offering of common stock.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!